Correlation Between NVIDIA and MIRA Pharmaceuticals,

Can any of the company-specific risk be diversified away by investing in both NVIDIA and MIRA Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NVIDIA and MIRA Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NVIDIA and MIRA Pharmaceuticals, Common, you can compare the effects of market volatilities on NVIDIA and MIRA Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NVIDIA with a short position of MIRA Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of NVIDIA and MIRA Pharmaceuticals,.

Diversification Opportunities for NVIDIA and MIRA Pharmaceuticals,

0.41

Correlation Coefficient

NVIDIA  MIRA Pharmaceuticals,

Very weak diversification

The 3 months correlation between NVIDIA and MIRA is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding NVIDIA and MIRA Pharmaceuticals, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MIRA Pharmaceuticals, and NVIDIA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NVIDIA are associated (or correlated) with MIRA Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MIRA Pharmaceuticals, has no effect on the direction of NVIDIA i.e., NVIDIA and MIRA Pharmaceuticals, go up and down completely randomly.

Pair Corralation between NVIDIA and MIRA Pharmaceuticals,

Given the investment horizon of 90 days NVIDIA is expected to under-perform the MIRA Pharmaceuticals,. But the stock apears to be less risky and, when comparing its historical volatility, NVIDIA is 1.41 times less risky than MIRA Pharmaceuticals,. The stock trades about -0.05 of its potential returns per unit of risk. The MIRA Pharmaceuticals, Common is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  118.00  in MIRA Pharmaceuticals, Common on December 27, 2024 and sell it today you would lose (3.00) from holding MIRA Pharmaceuticals, Common or give up 2.54% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

NVIDIA  vs.  MIRA Pharmaceuticals, Common

NVIDIA

Risk-Adjusted Performance

Very Weak

Over the last 90 days NVIDIA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

MIRA Pharmaceuticals,

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in MIRA Pharmaceuticals, Common are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, MIRA Pharmaceuticals, may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with NVIDIA and MIRA Pharmaceuticals,

The main advantage of trading using opposite NVIDIA and MIRA Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NVIDIA position performs unexpectedly, MIRA Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MIRA Pharmaceuticals, will offset losses from the drop in MIRA Pharmaceuticals,'s long position.

The idea behind NVIDIA and MIRA Pharmaceuticals, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.